Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal
The Advisory Committee on Immunization Practices (ACIP) recently recommended that adults who are 60 years of age and older may receive one of the new respiratory syncytial virus (RSV) vaccines after consulting with their healthcare providers but did not recommend them for all older adults without that discussion.
Pablo Sanchez, MD, an infectious disease physician at The Ohio State